Insider · CIK 0001365618
Hove Anders D
Reports to the SEC for 12 companies · NEW YORK, NY
Transactions
50
Companies
12
Filings
9
CIK
0001365618
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2024-01-30 | ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2022-12-15 | ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2021-01-12 | ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2018-03-01 | ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2017-02-16 | ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2016-06-24 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2016-06-24 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2016-06-24 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2016-06-24 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2016-06-24 | Anacor Pharmaceuticals, Inc.D Disposition to Issuer | −$3.36M |
| 2016-06-24 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2016-06-24 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2016-05-16 | Anacor Pharmaceuticals, Inc.S Sale | −$7.16M |
| 2016-05-16 | Anacor Pharmaceuticals, Inc.S Sale | −$19.9M |
| 2016-05-16 | Anacor Pharmaceuticals, Inc.S Sale | −$8.21M |
| 2016-04-14 | Anacor Pharmaceuticals, Inc.2.00% Convertible Senior Notes due 2021C Conversion | — |
| 2016-04-14 | Anacor Pharmaceuticals, Inc.C Conversion | +$8M |
| 2016-04-08 | Anacor Pharmaceuticals, Inc.S Sale | −$28.6K |
| 2016-04-08 | Anacor Pharmaceuticals, Inc.S Sale | −$271K |
| 2016-04-07 | Anacor Pharmaceuticals, Inc.S Sale | −$7.23M |
| 2016-04-07 | Anacor Pharmaceuticals, Inc.S Sale | −$515K |
| 2016-04-07 | Anacor Pharmaceuticals, Inc.S Sale | −$14.8K |
| 2016-04-07 | Anacor Pharmaceuticals, Inc.S Sale | −$167K |
| 2016-04-07 | Anacor Pharmaceuticals, Inc.S Sale | −$938K |
| 2016-04-07 | Anacor Pharmaceuticals, Inc.S Sale | −$7.14M |
| 2015-12-15 | Anacor Pharmaceuticals, Inc.S Sale | −$100M |
| 2015-12-11 | Anacor Pharmaceuticals, Inc.S Sale | −$4.69M |
| 2015-11-10 | Anacor Pharmaceuticals, Inc.S Sale | −$10.4M |
| 2015-11-10 | Anacor Pharmaceuticals, Inc.J Other | — |
| 2015-11-10 | Anacor Pharmaceuticals, Inc.J Other | — |
| 2015-11-03 | Anacor Pharmaceuticals, Inc.J Other | — |
| 2015-11-03 | Anacor Pharmaceuticals, Inc.J Other | — |
| 2015-11-03 | Anacor Pharmaceuticals, Inc.J Other | — |
| 2015-11-03 | Anacor Pharmaceuticals, Inc.J Other | — |
| 2015-10-06 | PDSBPDS Biotechnology CorpJ Other | +$401K |
| 2015-10-06 | PDSBPDS Biotechnology Corp · Series C-2 Convertible Preferred StockC Conversion | — |
| 2015-10-06 | PDSBPDS Biotechnology CorpP Purchase | +$4.95M |
| 2015-10-06 | PDSBPDS Biotechnology CorpC Conversion | — |
| 2015-06-09 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)A Award | — |
| 2015-06-09 | Anacor Pharmaceuticals, Inc.A Award | — |
| 2014-10-16 | Anacor Pharmaceuticals, Inc.2.00% Convertible Debentures due 2021A Award | — |
| 2014-10-16 | Anacor Pharmaceuticals, Inc.2.00% Convertible Senior Notes due 2021A Award | — |
| 2014-09-26 | Anacor Pharmaceuticals, Inc.S Sale | −$500K |
| 2014-09-19 | Anacor Pharmaceuticals, Inc.S Sale | −$18.4M |
| 2014-09-18 | Anacor Pharmaceuticals, Inc.S Sale | −$37.3K |
| 2014-09-16 | Anacor Pharmaceuticals, Inc.S Sale | −$1.87M |
| 2014-09-12 | Anacor Pharmaceuticals, Inc.S Sale | −$375K |
| 2013-11-15 | Anacor Pharmaceuticals, Inc.S Sale | −$2.11M |
| 2013-06-06 | Anacor Pharmaceuticals, Inc.Stock Option (right to buy)A Award | — |
| 2012-09-20 | Anacor Pharmaceuticals, Inc.S Sale | −$121K |
Recent filings
- 4Hove Anders D0001209191-24-002481SEC(opens sec.gov)
- 4Hove Anders D0001209191-22-061911SEC(opens sec.gov)
- 4Hove Anders D0001209191-21-003472SEC(opens sec.gov)
- 4Hove Anders D0001209191-18-016685SEC(opens sec.gov)
- 4ARCA biopharma, Inc.0001209191-17-012755SEC(opens sec.gov)
- 4Anacor Pharmaceuticals, Inc.0000950103-16-014342SEC(opens sec.gov)
- 4Anacor Pharmaceuticals, Inc.0001365618-16-000009SEC(opens sec.gov)
- 4Anacor Pharmaceuticals, Inc.0001365618-16-000008SEC(opens sec.gov)
- 4Anacor Pharmaceuticals, Inc.0001365618-16-000007SEC(opens sec.gov)
Companies
- Adverum Biotechnologies, Inc.10% Owner
- ALIMERA SCIENCES INCDirector, 10% Owner
- Anacor Pharmaceuticals, Inc.Director
- Chelsea Therapeutics International, Ltd.10% Owner
- Inspire Medical Systems, Inc.10% OwnerINSP
- IRONWOOD PHARMACEUTICALS INC10% OwnerIRWD
- NEUROCRINE BIOSCIENCES INC10% OwnerNBIX
- OnKure Therapeutics, Inc.10% OwnerOKUR
- Oruka Therapeutics, Inc.DirectorORKA
- PDS Biotechnology CorpDirectorPDSB
- Trubion Pharmaceuticals, IncDirector
- WORLD HEART CORPDirector, 10% Owner
Address
C/O VENROCK ASSOCIATES 30 ROCKEFELLER PLAZA, ROOM 5508
NEW YORK, NY, 10112